Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Novonesis A/S
Novonesis makes industrial enzymes and microbial ingredients that help other companies make everyday products more efficiently and sustainably.
Novonesis is a Danish biotech company that sells the invisible workers behind many everyday products. Its main products are enzymes — proteins that speed up chemical reactions — and live microbes. Laundry detergent makers add its enzymes to break down stains at low temperatures, so you can wash clothes in cold water and still get them clean. Food and beverage companies use them to keep bread fresh longer or turn starch into sugar. Farmers use its microbes to help crops take up nutrients, and bioenergy producers use enzymes to squeeze more fuel out of corn and waste.
The company was formed in early 2024 when Novozymes, the world's biggest enzyme maker, merged with Chr. Hansen, a Danish maker of cultures, probiotics, and natural colors. The combined firm took the name Novonesis, which is why some stock screens still show the old Novozymes label. The logic of the deal was scale and reach: Novozymes brought industrial enzyme muscle, while Chr. Hansen added food cultures, probiotics for human health and animal feed, and natural pigments. Together they sell into household care, food and drink, bioenergy, agriculture, and pharmaceuticals. Customers pay Novonesis because its ingredients let them cut costs, use less energy and water, and make products that meet stricter environmental rules. A detergent maker that can wash at 30°C instead of 60°C saves real money on electricity, and that is the pitch. The company invests heavily in research and holds a deep patent portfolio, which is its main moat. Rivals include large chemical and biotech players such as Novartis-adjacent specialty suppliers and DSM-Firmenich in some enzyme and nutrition areas, though Novonesis is the clear leader in industrial enzymes.
The business is steady rather than explosive. Enzymes are a small cost for customers but deliver big savings, so demand tends to hold up even in weak economies — a quiet, recurring-revenue quality. Novonesis spends a meaningful chunk of its cash on research and development, pays a dividend, and has used buybacks to return cash to shareholders. The main risks are pricing pressure from cheaper competitors, slower growth in mature markets like laundry detergent, and the hard work of stitching two large companies into one. So far the merger has been the biggest story, and how well the combined firm executes will decide whether it earns its premium.
Saved answer · last researched 12 Nov 2026